Test Code FPHNY PHENYTOIN (DILANTIN®), FREE, SERUM
Additional Codes
Software | Test Code |
---|---|
Label Text | FPHNY |
EPIC | LAB32 |
Performing Laboratory
NorDx Laboratories
Useful For
Monitoring phenytoin levels
Phenytoin is the drug of choice to treat and prevent tonic-clonic and psychomotor seizures. If phenytoin alone will not prevent seizure activity, co-administration with phenobarbital is usually effective.
Method Name
Spectrophotometry (SP)
Reference Values
Therapeutic concentration: 1.2-2.5 ug/mL
Toxic concentration: > 3.0 ug/mL
Free PHENYTOIN levels should be drawn as a trough (2 hours prior to the next scheduled dose) after 3-4 days of therapy to ensure steady state is achieved, unless there is concern for toxicity in which case levels can be checked anytime. Free PHENYTOIN concentration is recommended in patients with uremia, hypoalbuminemia, hyperbilirubinemia, hepatic impairment or concomitant medicactions that may displace PHENYTOIN from its albumin binding sites
Days and Times Test Performed
Monday through Sunday
Report Available
1 Day
Available Stat
Specimen Type
Serum
Preferred Container
Red Top Tube
Preferred Volume
Serum: 2 mL (Red Top Tube)
Minimum Volume
Serum: 1 mL (Red Top Tube)
Specimen Collection and Handling
1. Spin specimen, separate from clot and send refrigerated.
2. Fosphenytoin and phenytoin levels are best measured as a trough level, with specimen collection being performed 2 hours PRIOR to the next dose.
Specimen Stability Information
Specimen Type: Serum
Frozen: 3 Months
Refrigerated: 6 Days
Must be spun/separated within: 2 Hours
Add On Capable
Yes
Advance Beneficiary Notice Requirements
No ABN Required
CPT Code Information
CPT Code |
CPT Description |
CPT Disclaimer |
---|---|---|
80186 | Drug Screen Quantitative Phenytoin, Free |
Keywords
DILANTIN® (PHENYTOIN)
DIPHENYLHYDANTOIN
FREE DILANTIN® (PHENYTOIN)
PHENYTOIN (DILANTIN®)
Performing Laboratory Location
NorDx Laboratories
Clinical Significance
Biotin interference would falsely increase the result of this assay.
LOINC Code Information
3969-3